Preoperative Evaluation of Patients Undergoing Thoracic Surgery

CHAPTER 3 Preoperative Evaluation of Patients Undergoing Thoracic Surgery




The decision to proceed with any surgical procedure involves a careful consideration of the anticipated benefits of surgery and an assessment of the risks associated with the surgical procedure. An important component of estimating the benefit of surgery is knowledge of the natural history of the condition in question in the absence of surgery.


A popular, and inaccurate, conception of preoperative evaluation is that the evaluating physician “clears” the patient for surgery. Implicit in this terminology is the assumption that a cleared patient has a low risk for perioperative morbidity. As will be discussed in this chapter, it is more accurate to view the role of preoperative evaluation as meeting two goals: defining the morbidity and risks of surgery, both short term and long term, and identifying specific factors or conditions in patients that can be addressed to modify the patient’s risk of morbidity. The formulation of an approach to accomplish these goals requires knowledge of the effects of thoracic surgery on patients.



PHYSIOLOGIC EFFECTS OF THORACIC SURGERY


Surgical procedures and the anesthesia administered to allow such procedures have significant impact on respiratory physiology that contributes to the development of postoperative pulmonary complications. Given that the incidence of pulmonary complications is directly related to the proximity of the planned procedure to the diaphragms, patients undergoing pulmonary, esophageal, or other thoracic surgical procedures fall into the category of patients at high risk for postoperative respiratory complication.1


The intraoperative use of inhaled volatile agents can affect gas exchange by altering diaphragmatic and chest wall function. These changes occur without corresponding alterations in blood flow, which creates low ventilation-perfusion areas, resulting in widening of the alveolar-arterial oxygen gradient.


In the postoperative period, a variety of factors contribute to the development of complications. These include an alteration in breathing pattern to one of rapid shallow breaths with the absence of periodic deep breaths (sighs) and abnormal diaphragmatic function. These result both from pain and from diaphragmatic dysfunction resulting from splanchnic efferent neural impulses arising from the manipulation of abdominal contents. This has the effect of reducing the functional residual capacity (FRC), the resting volume of the respiratory system. The FRC declines by an average of 35% after thoracotomy and lung resection and by about 30% after upper abdominal operations.24 If the FRC declines sufficiently to approach closing volume, the volume at which small airway closure begins to occur, patients develop atelectasis and are predisposed to infectious complications. Closing volume is elevated in patients with underlying lung disease.


The alterations in lung volumes that occur result in a reduction in both the inspiratory capacity (the maximal inhalation volume attained starting from a given lung volume) and the expiratory reserve volume (the maximal exhalation volume from a given lung volume), contribute to a decline in the effectiveness of cough, and result in increased difficulty in clearing of pulmonary secretions.



PATIENT POPULATION UNDERGOING THORACIC SURGERY


Many patients undergoing a noncardiac thoracic surgical procedure do so because of known or suspected lung or esophageal cancer. These diseases share the common risk factor of a significant and prolonged exposure to cigarette smoking. The combination of age and prolonged cigarette smoking results in a patient population with a significant incidence of comorbid factors in addition to the primary diagnosis. Several reports use the Charlson Comorbidity Index as an indicator of comorbid conditions and predictor of postoperative complications. This index generates a score based on the presence of comorbid conditions and has been demonstrated to stratify risk of postoperative complications in thoracic surgery patients.5,6


In one study, the mean age of patients undergoing esophagectomy was 58.1 years; 45% of patients were older than 60 years.7 In another Japanese study, the median age was 62.3 years; 88% were male.8 In a study comparing transhiatal esophagectomy with transthoracic esophagectomy, the mean ages of the patients were 69 years and 64 years, with patients up to the age of 79 years included in the study.9 In a review, 28% to 32% of patients undergoing esophagectomy in the United States were older than 75 years, and 40% had a Charlson score above 3.10


Similarly, patients with lung cancer tend to be older and have comorbid conditions. In a series of 344 patients, 36% were older than 70 years and 95% had a significant smoking history.11 A review of Medicare patients undergoing thoracic surgery in the United States showed that of patients undergoing lobectomy, 32% to 35% were older than 75 years (44% women), and 32% had a Charlson score above 3.10 In the same series, 21% to 26% of patients undergoing pneumonectomy were older than 75 years (28% women), and 56% had a Charlson score above 3.


A significant source of comorbidity in the population of patients with lung cancer is chronic obstructive pulmonary disease (COPD). The diagnosis of COPD is an independent risk factor, controlling for cigarette smoke exposure, for the development of lung cancer.


Thus, the patient population presenting for major thoracic surgical procedures tends to be older, has a high incidence of comorbid conditions, and contains a disproportionate number of patients with obstructive lung disease. The combination of these factors, plus the magnitude of the surgical procedures, presents a challenge to the clinicians evaluating such patients. The potential for perioperative morbidity and mortality is substantial, but at the same time, the lack of effective alternative therapy for the patient’s malignant disease means that the consequence of not being a surgical candidate is almost certain mortality. This quandary has led Gass and Olsen12 to ask, What is an acceptable surgical mortality in a disease with 100% mortality?





HISTORY AND PHYSICAL EXAMINATION


Although the field of thoracic surgery has been dramatically altered by the development of new technologies in both imaging and therapeutics, the history and physical examination remain the most important components of the preoperative evaluation. There is no substitute for a careful history and examination by an experienced clinician.



History


Table 3-1 highlights the important components of the patient’s history. Whereas many of the elements of the history are self-explanatory, several require some further exposition. A critical component of the preoperative evaluation is the assessment of a patient’s functional status. Functional status is an important component of the decision algorithm for both the pulmonary and cardiac elements of the preoperative evaluation. A variety of approaches have been taken to determine functional capacity. These include questionnaires; tests of locomotion, such as the 6-minute walk or stair climbing; and cardiopulmonary exercise testing (discussed later). One convenient approach to use is the Duke Activity Status Index (DASI) (Table 3-2), a questionnaire that can be administered during an interview or can be self-administered.15


Table 3–1 Important Components of History in Preoperative Evaluation



















Presenting symptoms and circumstances of diagnosis
Prior diagnosis of pulmonary or cardiac disease
Comorbid conditions: diabetes mellitus, liver disease, renal disease
Prior experiences with general anesthesia and surgery
Cigarette smoking: never, current, ex-smoker (if ex-smoker, when did patient stop?)
Inventory of functional capacity of patient (e.g., Duke Activity Status Index)
Medications and allergies
Alcohol use, including prior history of withdrawal syndromes


There is a rough correlation between the score on the DASI, which ranges from 0 to 58.2, and maximal oxygen uptake. In addition, the answers to this questionnaire can be used to estimate the functional capacity of the patient in metabolic equivalents (METs), as described in the section on cardiac assessment.


In addition to these considerations, patients should be asked about signs or symptoms suggesting the presence of metastatic disease. These include new headaches, focal neurologic signs or symptoms, new-onset seizure disorder, bone pain, and recent fractures. Patients should also be questioned about symptoms related to paraneoplastic syndromes. These can range from the relatively subtle symptoms of hypercalcemia to more dramatic neurologic symptoms.



Physical Examination


The examination of the patient includes an assessment of general overall appearance, including signs of wasting. Respiratory rate and the use of accessory muscles of respiration are noted. Examination of the head and neck includes assessment of adenopathy and focal neurologic deficits or signs, particularly Horner’s syndrome in patients with a lung mass. The pulmonary examination includes an assessment of diaphragmatic motion (by percussion) and notes any paradoxical respiratory pattern in the recumbent position. The relative duration of exhalation as well as the presence or absence of wheezing should be noted. The presence of rales should raise the possibility of pneumonia, heart failure, or pulmonary fibrosis. The cardiac examination includes assessment of a third heart sound to suggest left ventricular failure, murmurs to suggest valvular lesions, and an accentuated pulmonic component of the second heart sound suggestive of pulmonary hypertension. The heart rhythm and the absence or presence of any irregular heart beats are noted. The abdominal examination notes liver size, presence or absence of palpable masses or adenopathy, and any tenderness. The examination of extremities notes any edema, cyanosis, or clubbing. Clubbing should not be attributed to COPD and raises the possibilities of intrathoracic malignant disease or congenital heart disease. The patient’s gait should be observed, both as an assessment of neurologic function and to confirm the patient’s ability to participate in postoperative mobilization.



< div class='tao-gold-member'>

Jul 30, 2016 | Posted by in CARDIAC SURGERY | Comments Off on Preoperative Evaluation of Patients Undergoing Thoracic Surgery
Premium Wordpress Themes by UFO Themes